Teva Pharmaceutical Industries Comprehensive Income 2010-2024 | TEVA

Teva Pharmaceutical Industries comprehensive income for the quarter ending December 31, 2024 was $-3.148B, a 16.72% increase year-over-year.

  • Teva Pharmaceutical Industries comprehensive income for 2024 was $-3.148B, a 16.72% increase from 2023.
  • Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
  • Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.

Teva Pharmaceutical Industries Comprehensive Income 2010-2024 | TEVA

  • Teva Pharmaceutical Industries comprehensive income for 2024 was $-3.148B, a 16.72% increase from 2023.
  • Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
  • Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$11.2B
BridgeBio Pharma (BBIO)$6.9B
Bausch Health Cos (BHC)$2.4B
Supernus Pharmaceuticals (SUPN)$1.9B
Amphastar Pharmaceuticals (AMPH)$1.5B
Personalis (PSNL)$412M
Taysha Gene Therapies (TSHA)$336M
Assembly Biosciences (ASMB)$81M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$8M
Teligent (TLGT)$0M